A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dow Pharmaceutical Sciences

Criteria

Inclusion Criteria:

• Presence of inflammatory and non-inflammatory lesions

Exclusion Criteria:

• Dermatological conditions of the face that could interfere with clinical evaluations

• Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study